Astellas Boosts COVID-19 Measures after State of Emergency Declared; Daiichi Sankyo Partially Pausing Trials

April 10, 2020
Japan’s pharma companies are moving toward upscaling their corporate measures against the novel coronavirus disease COVID-19 in response to the government’s declaration of a state of emergency on April 8. Astellas Pharma has introduced tougher measures for its employees in...read more